Singular Health Group Ltd (ASX: SHG) Share Price and News

Price

Movement

( )

(20 mins delayed)

52 Week Range

-

 
1 Year Return

 

Singular Health Group Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $59.85 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 260.20 million
Earnings per share -0.022
Dividend per share N/A
Year To Date Return 2.22%
Earnings Yield N/A
Franking -
Share Price

Day Change

( )

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

  • Should you invest $1,000 in Singular Health Group Ltd right now?

    Before you buy Singular Health Group Ltd shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Singular Health Group Ltd wasn't one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys...

    See The 5 Stocks *Returns as of 6 March 2025

  • Singular Health Group Ltd (ASX: SHG)
    Latest News

    asx share initial public offering or IPO represented by hands holding up sign saying welcome aboard
    Share Market News

    Singular Health (ASX:SHG) shares arrive on the ASX

    Singular Health Group Ltd (ASX: SHG) shares are set to float on the ASX today, following a heavily oversubscribed capital…

    Read more »

    SHG ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About Singular Health Group Ltd

    Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia.

    SHG Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    17 Mar 2025 $0.23 $0.00 0.00% 114,424 $0.23 $0.23 $0.23
    14 Mar 2025 $0.23 $0.00 0.00% 368,114 $0.23 $0.23 $0.22
    13 Mar 2025 $0.23 $0.02 9.30% 239,380 $0.22 $0.23 $0.22
    12 Mar 2025 $0.22 $-0.01 -4.55% 1,214,110 $0.22 $0.22 $0.21
    11 Mar 2025 $0.22 $-0.02 -8.51% 355,720 $0.24 $0.24 $0.22
    10 Mar 2025 $0.24 $0.02 9.30% 61,526 $0.22 $0.24 $0.22
    07 Mar 2025 $0.22 $0.00 0.00% 710,228 $0.22 $0.24 $0.22
    06 Mar 2025 $0.22 $-0.02 -8.70% 284,759 $0.23 $0.24 $0.22
    05 Mar 2025 $0.23 $0.00 0.00% 190,722 $0.23 $0.23 $0.22
    04 Mar 2025 $0.23 $0.00 0.00% 1,296,619 $0.25 $0.25 $0.22
    03 Mar 2025 $0.24 $-0.01 -4.08% 739,985 $0.24 $0.25 $0.24
    28 Feb 2025 $0.25 $-0.02 -7.55% 227,174 $0.27 $0.27 $0.25
    27 Feb 2025 $0.27 $0.02 8.00% 429,664 $0.26 $0.28 $0.25
    26 Feb 2025 $0.25 $-0.03 -10.91% 802,484 $0.28 $0.28 $0.25
    25 Feb 2025 $0.28 $0.02 7.69% 716,351 $0.27 $0.29 $0.26
    24 Feb 2025 $0.26 $-0.02 -7.27% 178,789 $0.27 $0.27 $0.26
    21 Feb 2025 $0.28 $0.03 12.00% 2,780,090 $0.26 $0.28 $0.25
    20 Feb 2025 $0.25 $0.02 8.70% 495,434 $0.25 $0.26 $0.24
    19 Feb 2025 $0.23 $-0.02 -8.00% 283,256 $0.25 $0.25 $0.23
    18 Feb 2025 $0.25 $0.01 4.17% 344,845 $0.25 $0.26 $0.24

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    10 Feb 2025 Howard Digby Expiry 1,000,000 $240,000
    Options expired.
    10 Feb 2025 Andrew Just Expiry 1,000,000 $240,000
    Options expired.
    10 Feb 2025 Denning Chong Expiry 4,500,000 $1,080,000
    Options expired.
    20 Jan 2025 Denning Chong Buy 4,000,000 $960,000
    Conversion of securities.
    20 Jan 2025 Denning Chong Exercise 4,000,000 $960,000
    Conversion of securities. 12,000,000 - Performance Rights
    09 Jan 2025 Denning Chong Expiry 1,200,000 $270,000
    As advised by the company. 16,000,000 - Performance Rights
    Lapse of unvested performance rights
    25 Jul 2024 Andrew Just Issued 336,364 $33,300
    Director remuneration. Estimated value
    25 Jul 2024 Howard Digby Issued 378,218 $37,443
    Director remuneration. Estimated value
    25 Jul 2024 Denning Chong Issued 10,000,000 $910,000
    Issue of securities. 17,200,000 Rights
    25 Jul 2024 Denning Chong Exercise 1,500,000 $136,500
    Conversion of securities. 7,200,000 Rights
    25 Jul 2024 Denning Chong Issued 1,500,000 $136,500
    Conversion of securities.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Andrew Ian Just Non-Executive Director Jan 2021
    Mr Just was formerly the Regional Director Asia Pacific for Radiometer, a Danaher Company and is currently CEO of Aeris Environmental. He has 30 years' global experience in delivering growth and scale competencies with Fortune 500 companies, including GE Healthcare, Danaher, Stryker, and Cochlear. Andrew has senior roles across business functions, with expertise in sales and marketing, performance management, commercial transactions, and operations in both turnaround and growth environments. He is also a Member of the Risk Committee.
    Mr Howard Andrew Digby Non-Executive ChairmanNon-Executive Director Jan 2021
    Mr Digby began his career at IBM and has spent over 25 years managing technology-related businesses in the Asia Pacific region, of which 11 years were spent in Hong Kong. Prior to returning to Perth, Howard was with The Economist Group as Regional Managing Director. He has also held senior regional management roles at Adobe and Gartner.
    Mr Denning Sang-Tatt Chong Chief Executive OfficerManaging Director Apr 2023
    Mr Chong has been the principal of James Chong Lawyers since 2004. Denning has had the opportunity to assist across a spectrum of the community - from ASX listed companies and cross border type transactions, to local communities. Denning holds positions with various prominent property development companies, including currently being a director of the Australian subsidiaries of a prominent SGX listed property developer, with a property portfolio. He is also a director of a boutique venture capital business focusing on property, financial and medical technology sectors. He is a Member of the Risk Committee
    Mr Steven Douglas Wood Company Secretary
    -
    Steven Douglas Wood Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Marin And Sons Strategies Llc 13,636,363 6.60%
    Mr Sim Tek Tan 9,003,091 4.35%
    Chong Ling Diamond Cheong 7,065,754 3.42%
    Mr Craig Sellars 6,666,667 3.22%
    Statewide National Services Pty Ltd 6,000,000 2.90%
    Skyline Corporation Pty Ltd 5,068,539 2.45%
    Jli Enterprises Pty Ltd <Jli A/C> 4,900,000 2.37%
    Jcc Health Pty Ltd <The Jde Medvr A/C> 4,640,869 2.24%
    Sylvan Capital Pte Ltd 3,500,000 1.69%
    Ms Wei Zheng 3,326,224 1.61%
    Mr Anthony Galvin Khang Chuang Lim 3,192,359 1.54%
    Jde Capital Pty Ltd <Jde Capital A/C> 3,167,706 1.53%
    Mr Qingyuan Zhang 3,136,364 1.52%
    Mr Pak Lim Kong 3,132,292 1.51%
    Garry Tet Kheng Chong 3,000,000 1.45%
    Mr Kostadin Jivkov Manolev 2,828,821 1.37%
    Mr Ilia Manolev 2,713,878 1.31%
    Peninsula Treescape Pty Ltd <The Cardinals A/C> 2,700,000 1.31%
    Raffe Capital Pty Ltd 2,272,727 1.10%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 2,154,683 1.06%

    Profile

    since

    Note